Oviva

Summary

Seedtable Score

60

Locations

• London

Company Size

• 251 to 500

Last Stage Round

• Unknown

Industry

• CPG & Consumer Goods
• Ecommerce
• Foodtech

Insights

Oviva addresses a critical need in modern healthcare by digitizing the treatment of type 2 diabetes and obesity. Based in London, the company offers a platform that facilitates behavior change through digital solutions, providing a scalable alternative to traditional consultations. By focusing on chronic conditions, Oviva targets a market with a significant need for better management and monitoring, potentially improving health outcomes and reducing healthcare costs. Their B2B model enables partnerships with healthcare providers and insurers, integrating seamlessly into existing systems. Supported by investors like AlbionVC and Earlybird Venture Capital, Oviva is positioned to expand its market presence and drive innovation in health tech.

• 2021 Unknown $80.0M

---

• 2020 Series B $21.0M

---

Investors

• AlbionVC Unknown

---

• Earlybird Venture Capital Unknown

---

• Eight Roads Ventures Unknown

---

• AlbionVC Series B

---

• Earlybird Venture Capital Series B

---

• Eight Roads Ventures Series B

---

• Partech Ventures Series B

---